JiangsuJibeier Pharmaceutical (688566) Stock Overview

Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research, development, production, and sale of chemical pharmaceutical preparations, Chinese medicine, and drugs. The company's products cover various therapeutic areas, such as improving white blood cells, anti-hypertension, enhancing immunity, treating joint diseases, anti-eye infection, treating bronchitis, protecting liver function, and other therapeutic fields. It is also developing drugs for the treatment of depression, tumors, stomach and gastric diseases, and other diseases. In addition, the company offers its products in tablets, capsules, and eye drops dosage forms. Jiangsu Jibeier Pharmaceutical Co., Ltd. was founded in 2001 and is based in Zhenjiang, China.